Related Experiment Video
Updated: Jun 12, 2025
07:50
Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model
Published on: September 3, 2020
4.6K
Immunomodulatory Therapy for Ischemic Heart Disease
Xinye Zhao1,2, Thomas Williamson1,3, Yanqing Gong1,4
1Cardiovascular Institute (X.Z., T.W., Y.G., J.A.E., Y.F.), Perelman School of Medicine, University of Pennsylvania, Philadelphia.
Circulation
|September 26, 2024
Summary
Immunotherapy offers new hope for ischemic heart disease by reprogramming the immune microenvironment. Strategies include targeting vascular cells, myeloid cells, and T cells to restore cardiac function after myocardial infarction.
Area of Science:
- Cardiovascular Medicine
- Immunology
- Regenerative Medicine
Background:
- Ischemic heart disease is a major global cause of mortality.
- Myocardial infarction leads to impaired cardiac function and heart failure.
- Current treatments for restoring cardiac function post-myocardial infarction are limited.
Purpose of the Study:
- To explore immunotherapy as a novel treatment for ischemic cardiomyopathy.
- To highlight emerging immunomodulatory strategies for cardiac repair.
Main Methods:
- Review of recent research on immunotherapy for ischemic heart disease.
- Focus on three key strategies: targeting vascular endothelial cells, reprogramming myeloid cells, and adoptive T cell therapy.
Main Results:
- Impaired tissue immunity exacerbates cardiac dysfunction after myocardial infarction.
- Immunotherapy can recalibrate the immune microenvironment.
- Targeting specific immune and stroma cells shows promise for treatment.
Conclusions:
- Immunomodulatory therapies hold significant promise for treating ischemic heart disease.
- Emerging strategies offer potential for restoring cardiac function and ameliorating fibrosis.
Related Concept Videos
01:14Myocarditis III: Medical Management
2
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
2
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
396
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
396
01:17Ischemic Heart Disease: Overview
1.2K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.2K
01:28Acute Coronary Syndrome IV: Interprofessional Care
3
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
3
01:22Myocarditis IV: Nursing Management
2
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
2
01:29Cardiomyopathy V: Interprofessional Care
2
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
2